APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chronic Kidney Disease Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Chronic Kidney Disease Drugs Market Analysis and Forecast 2026-2032

26 December 2025198 pages

Choose your research edition.

Industry ResearchChronic Kidney Disease Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Kidney Disease Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Chronic Kidney Disease Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Kidney Disease Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Kidney Disease Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Chronic Kidney Disease Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Chronic Kidney Disease Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Chronic Kidney Disease Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Chronic Kidney Disease Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Chronic Kidney Disease Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Chronic Kidney Disease Drugs include AstraZeneca, F. Hoffmann-La Roche Ltd, Keryx Biopharmaceuticals, Inc, Kissei Pharmaceutical Co., Ltd, AbbVie, Amgen, GlaxoSmithKline, Pfizer and Sanofi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Chronic Kidney Disease Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Chronic Kidney Disease Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Chronic Kidney Disease Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Chronic Kidney Disease Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Chronic Kidney Disease Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Chronic Kidney Disease Drugs sales, projected growth trends, production technology, application and end-user industry.

Chronic Kidney Disease Drugs Segment by Company

AstraZeneca

F. Hoffmann-La Roche Ltd

Keryx Biopharmaceuticals, Inc

Kissei Pharmaceutical Co., Ltd

AbbVie

Amgen

GlaxoSmithKline

Pfizer

Sanofi

Teva Pharmaceutical Industries

Chronic Kidney Disease Drugs Segment by Type

Beta Blockers

Calcium Channel Blockers

Others

ACE Inhibitors

Chronic Kidney Disease Drugs Segment by Application

Hospitals

Specialty Clinics

Chronic Kidney Disease Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Kidney Disease Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Kidney Disease Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Kidney Disease Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Chronic Kidney Disease Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Chronic Kidney Disease Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chronic Kidney Disease Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Chronic Kidney Disease Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Beta Blockers Major Manufacturers Table 3. Calcium Channel Blockers Major Manufacturers Table 4. Others Major Manufacturers Table 5. ACE Inhibitors Major Manufacturers Table 6. Global Chronic Kidney Disease Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospitals Major Manufacturers Table 8. Specialty Clinics Major Manufacturers Table 9. Chronic Kidney Disease Drugs Industry Trends Table 10. Chronic Kidney Disease Drugs Industry Drivers Table 11. Chronic Kidney Disease Drugs Industry Opportunities and Challenges Table 12. Chronic Kidney Disease Drugs Industry Restraints Table 13. Global Chronic Kidney Disease Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Chronic Kidney Disease Drugs Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Chronic Kidney Disease Drugs Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Chronic Kidney Disease Drugs Revenue Market Share by Region (2021-2026) Table 17. Global Chronic Kidney Disease Drugs Revenue Market Share by Region (2027-2032) Table 18. Global Chronic Kidney Disease Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Tons) Table 19. Global Chronic Kidney Disease Drugs Sales by Region (2021-2026) & (W Tons) Table 20. Global Chronic Kidney Disease Drugs Sales by Region (2027-2032) & (W Tons) Table 21. Global Chronic Kidney Disease Drugs Sales Market Share by Region (2021-2026) Table 22. Global Chronic Kidney Disease Drugs Sales Market Share by Region (2027-2032) Table 23. Global Chronic Kidney Disease Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Chronic Kidney Disease Drugs Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Chronic Kidney Disease Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Chronic Kidney Disease Drugs Sales Market Share by Manufacturers (2021-2026) Table 27. Global Chronic Kidney Disease Drugs Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 28. Global Chronic Kidney Disease Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Chronic Kidney Disease Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Chronic Kidney Disease Drugs Manufacturers, Product Type & Application Table 31. Global Chronic Kidney Disease Drugs Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Chronic Kidney Disease Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Chronic Kidney Disease Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Chronic Kidney Disease Drugs Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Chronic Kidney Disease Drugs Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Chronic Kidney Disease Drugs Revenue Market Share by Type (2021-2026) Table 38. Global Chronic Kidney Disease Drugs Revenue Market Share by Type (2027-2032) Table 39. Global Chronic Kidney Disease Drugs Sales by Type 2021 VS 2025 VS 2032 (W Tons) Table 40. Global Chronic Kidney Disease Drugs Sales by Type (2021-2026) & (W Tons) Table 41. Global Chronic Kidney Disease Drugs Sales by Type (2027-2032) & (W Tons) Table 42. Global Chronic Kidney Disease Drugs Sales Market Share by Type (2021-2026) Table 43. Global Chronic Kidney Disease Drugs Sales Market Share by Type (2027-2032) Table 44. Global Chronic Kidney Disease Drugs Price by Type (2021-2026) & (US$/Ton) Table 45. Global Chronic Kidney Disease Drugs Price by Type (2027-2032) & (US$/Ton) Table 46. Global Chronic Kidney Disease Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Chronic Kidney Disease Drugs Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Chronic Kidney Disease Drugs Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Chronic Kidney Disease Drugs Revenue Market Share by Application (2021-2026) Table 50. Global Chronic Kidney Disease Drugs Revenue Market Share by Application (2027-2032) Table 51. Global Chronic Kidney Disease Drugs Sales by Application 2021 VS 2025 VS 2032 (W Tons) Table 52. Global Chronic Kidney Disease Drugs Sales by Application (2021-2026) & (W Tons) Table 53. Global Chronic Kidney Disease Drugs Sales by Application (2027-2032) & (W Tons) Table 54. Global Chronic Kidney Disease Drugs Sales Market Share by Application (2021-2026) Table 55. Global Chronic Kidney Disease Drugs Sales Market Share by Application (2027-2032) Table 56. Global Chronic Kidney Disease Drugs Price by Application (2021-2026) & (US$/Ton) Table 57. Global Chronic Kidney Disease Drugs Price by Application (2027-2032) & (US$/Ton) Table 58. AstraZeneca Company Information Table 59. AstraZeneca Business Overview Table 60. AstraZeneca Chronic Kidney Disease Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. AstraZeneca Chronic Kidney Disease Drugs Product Portfolio Table 62. AstraZeneca Recent Development Table 63. F. Hoffmann-La Roche Ltd Company Information Table 64. F. Hoffmann-La Roche Ltd Business Overview Table 65. F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Product Portfolio Table 67. F. Hoffmann-La Roche Ltd Recent Development Table 68. Keryx Biopharmaceuticals, Inc Company Information Table 69. Keryx Biopharmaceuticals, Inc Business Overview Table 70. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Product Portfolio Table 72. Keryx Biopharmaceuticals, Inc Recent Development Table 73. Kissei Pharmaceutical Co., Ltd Company Information Table 74. Kissei Pharmaceutical Co., Ltd Business Overview Table 75. Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Product Portfolio Table 77. Kissei Pharmaceutical Co., Ltd Recent Development Table 78. AbbVie Company Information Table 79. AbbVie Business Overview Table 80. AbbVie Chronic Kidney Disease Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. AbbVie Chronic Kidney Disease Drugs Product Portfolio Table 82. AbbVie Recent Development Table 83. Amgen Company Information Table 84. Amgen Business Overview Table 85. Amgen Chronic Kidney Disease Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Amgen Chronic Kidney Disease Drugs Product Portfolio Table 87. Amgen Recent Development Table 88. GlaxoSmithKline Company Information Table 89. GlaxoSmithKline Business Overview Table 90. GlaxoSmithKline Chronic Kidney Disease Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. GlaxoSmithKline Chronic Kidney Disease Drugs Product Portfolio Table 92. GlaxoSmithKline Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Chronic Kidney Disease Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Pfizer Chronic Kidney Disease Drugs Product Portfolio Table 97. Pfizer Recent Development Table 98. Sanofi Company Information Table 99. Sanofi Business Overview Table 100. Sanofi Chronic Kidney Disease Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Sanofi Chronic Kidney Disease Drugs Product Portfolio Table 102. Sanofi Recent Development Table 103. Teva Pharmaceutical Industries Company Information Table 104. Teva Pharmaceutical Industries Business Overview Table 105. Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Product Portfolio Table 107. Teva Pharmaceutical Industries Recent Development Table 108. North America Chronic Kidney Disease Drugs Revenue by Type (2021-2026) & (US$ Million) Table 109. North America Chronic Kidney Disease Drugs Revenue by Type (2027-2032) & (US$ Million) Table 110. North America Chronic Kidney Disease Drugs Sales by Type (2021-2026) & (W Tons) Table 111. North America Chronic Kidney Disease Drugs Sales by Type (2027-2032) & (W Tons) Table 112. North America Chronic Kidney Disease Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 113. North America Chronic Kidney Disease Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 114. North America Chronic Kidney Disease Drugs Revenue by Application (2021-2026) & (US$ Million) Table 115. North America Chronic Kidney Disease Drugs Revenue by Application (2027-2032) & (US$ Million) Table 116. North America Chronic Kidney Disease Drugs Sales by Application (2021-2026) & (W Tons) Table 117. North America Chronic Kidney Disease Drugs Sales by Application (2027-2032) & (W Tons) Table 118. North America Chronic Kidney Disease Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 119. North America Chronic Kidney Disease Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 120. North America Chronic Kidney Disease Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America Chronic Kidney Disease Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 122. North America Chronic Kidney Disease Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 123. North America Chronic Kidney Disease Drugs Sales by Country (2021 VS 2025 VS 2032) & (W Tons) Table 124. North America Chronic Kidney Disease Drugs Sales by Country (2021-2026) & (W Tons) Table 125. North America Chronic Kidney Disease Drugs Sales by Country (2027-2032) & (W Tons) Table 126. North America Chronic Kidney Disease Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 127. North America Chronic Kidney Disease Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 128. United States Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 129. Canada Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 130. Mexico Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 131. Europe Chronic Kidney Disease Drugs Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe Chronic Kidney Disease Drugs Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe Chronic Kidney Disease Drugs Sales by Type (2021-2026) & (W Tons) Table 134. Europe Chronic Kidney Disease Drugs Sales by Type (2027-2032) & (W Tons) Table 135. Europe Chronic Kidney Disease Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 136. Europe Chronic Kidney Disease Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 137. Europe Chronic Kidney Disease Drugs Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe Chronic Kidney Disease Drugs Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe Chronic Kidney Disease Drugs Sales by Application (2021-2026) & (W Tons) Table 140. Europe Chronic Kidney Disease Drugs Sales by Application (2027-2032) & (W Tons) Table 141. Europe Chronic Kidney Disease Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 142. Europe Chronic Kidney Disease Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 143. Europe Chronic Kidney Disease Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Europe Chronic Kidney Disease Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Europe Chronic Kidney Disease Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Europe Chronic Kidney Disease Drugs Sales by Country (2021 VS 2025 VS 2032) & (W Tons) Table 147. Europe Chronic Kidney Disease Drugs Sales by Country (2021-2026) & (W Tons) Table 148. Europe Chronic Kidney Disease Drugs Sales by Country (2027-2032) & (W Tons) Table 149. Europe Chronic Kidney Disease Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 150. Europe Chronic Kidney Disease Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 151. Germany Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 152. France Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 153. U.K. Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 154. Italy Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 155. Russia Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 156. Spain Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 157. Netherlands Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 158. Switzerland Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 159. Sweden Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 160. Poland Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 161. China Chronic Kidney Disease Drugs Revenue by Type (2021-2026) & (US$ Million) Table 162. China Chronic Kidney Disease Drugs Revenue by Type (2027-2032) & (US$ Million) Table 163. China Chronic Kidney Disease Drugs Sales by Type (2021-2026) & (W Tons) Table 164. China Chronic Kidney Disease Drugs Sales by Type (2027-2032) & (W Tons) Table 165. China Chronic Kidney Disease Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 166. China Chronic Kidney Disease Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 167. China Chronic Kidney Disease Drugs Revenue by Application (2021-2026) & (US$ Million) Table 168. China Chronic Kidney Disease Drugs Revenue by Application (2027-2032) & (US$ Million) Table 169. China Chronic Kidney Disease Drugs Sales by Application (2021-2026) & (W Tons) Table 170. China Chronic Kidney Disease Drugs Sales by Application (2027-2032) & (W Tons) Table 171. China Chronic Kidney Disease Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 172. China Chronic Kidney Disease Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 173. Asia Chronic Kidney Disease Drugs Revenue by Type (2021-2026) & (US$ Million) Table 174. Asia Chronic Kidney Disease Drugs Revenue by Type (2027-2032) & (US$ Million) Table 175. Asia Chronic Kidney Disease Drugs Sales by Type (2021-2026) & (W Tons) Table 176. Asia Chronic Kidney Disease Drugs Sales by Type (2027-2032) & (W Tons) Table 177. Asia Chronic Kidney Disease Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 178. Asia Chronic Kidney Disease Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 179. Asia Chronic Kidney Disease Drugs Revenue by Application (2021-2026) & (US$ Million) Table 180. Asia Chronic Kidney Disease Drugs Revenue by Application (2027-2032) & (US$ Million) Table 181. Asia Chronic Kidney Disease Drugs Sales by Application (2021-2026) & (W Tons) Table 182. Asia Chronic Kidney Disease Drugs Sales by Application (2027-2032) & (W Tons) Table 183. Asia Chronic Kidney Disease Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 184. Asia Chronic Kidney Disease Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 185. Asia Chronic Kidney Disease Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. Asia Chronic Kidney Disease Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. Asia Chronic Kidney Disease Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. Asia Chronic Kidney Disease Drugs Sales by Country (2021 VS 2025 VS 2032) & (W Tons) Table 189. Asia Chronic Kidney Disease Drugs Sales by Country (2021-2026) & (W Tons) Table 190. Asia Chronic Kidney Disease Drugs Sales by Country (2027-2032) & (W Tons) Table 191. Asia Chronic Kidney Disease Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 192. Asia Chronic Kidney Disease Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 193. Japan Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 194. South Korea Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 195. India Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 196. Australia Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 197. Taiwan Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 198. Southeast Asia Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 199. SAMEA Chronic Kidney Disease Drugs Revenue by Type (2021-2026) & (US$ Million) Table 200. SAMEA Chronic Kidney Disease Drugs Revenue by Type (2027-2032) & (US$ Million) Table 201. SAMEA Chronic Kidney Disease Drugs Sales by Type (2021-2026) & (W Tons) Table 202. SAMEA Chronic Kidney Disease Drugs Sales by Type (2027-2032) & (W Tons) Table 203. SAMEA Chronic Kidney Disease Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 204. SAMEA Chronic Kidney Disease Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 205. SAMEA Chronic Kidney Disease Drugs Revenue by Application (2021-2026) & (US$ Million) Table 206. SAMEA Chronic Kidney Disease Drugs Revenue by Application (2027-2032) & (US$ Million) Table 207. SAMEA Chronic Kidney Disease Drugs Sales by Application (2021-2026) & (W Tons) Table 208. SAMEA Chronic Kidney Disease Drugs Sales by Application (2027-2032) & (W Tons) Table 209. SAMEA Chronic Kidney Disease Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 210. SAMEA Chronic Kidney Disease Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 211. SAMEA Chronic Kidney Disease Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 212. SAMEA Chronic Kidney Disease Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 213. SAMEA Chronic Kidney Disease Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 214. SAMEA Chronic Kidney Disease Drugs Sales by Country (2021 VS 2025 VS 2032) & (W Tons) Table 215. SAMEA Chronic Kidney Disease Drugs Sales by Country (2021-2026) & (W Tons) Table 216. SAMEA Chronic Kidney Disease Drugs Sales by Country (2027-2032) & (W Tons) Table 217. SAMEA Chronic Kidney Disease Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 218. SAMEA Chronic Kidney Disease Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 219. Brazil Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 220. Argentina Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 221. Chile Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 222. Colombia Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 223. Peru Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 224. Saudi Arabia Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 225. Israel Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 226. UAE Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 227. Turkey Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 228. Iran Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 229. Egypt Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Table 230. Key Raw Materials Table 231. Raw Materials Key Suppliers Table 232. Chronic Kidney Disease Drugs Distributors List Table 233. Chronic Kidney Disease Drugs Customers List Table 234. Research Programs/Design for This Report Table 235. Authors List of This Report Table 236. Secondary Sources Table 237. Primary Sources List of Figures Figure 1. Chronic Kidney Disease Drugs Image Figure 2. Global Chronic Kidney Disease Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chronic Kidney Disease Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Beta Blockers Image Figure 5. Calcium Channel Blockers Image Figure 6. Others Image Figure 7. ACE Inhibitors Image Figure 8. Global Chronic Kidney Disease Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Chronic Kidney Disease Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospitals Image Figure 11. Specialty Clinics Image Figure 12. Global Chronic Kidney Disease Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Chronic Kidney Disease Drugs Revenue (2021-2032) & (US$ Million) Figure 14. Global Chronic Kidney Disease Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Chronic Kidney Disease Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Chronic Kidney Disease Drugs Revenue Market Share by Region (2021-2032) Figure 17. Global Chronic Kidney Disease Drugs Sales (2021-2032) & (W Tons) Figure 18. Global Chronic Kidney Disease Drugs Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Figure 19. Global Chronic Kidney Disease Drugs Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Chronic Kidney Disease Drugs Sales YoY (2021-2032) & (W Tons) Figure 21. Europe Chronic Kidney Disease Drugs Sales YoY (2021-2032) & (W Tons) Figure 22. China Chronic Kidney Disease Drugs Sales YoY (2021-2032) & (W Tons) Figure 23. Asia (Excluding China) Chronic Kidney Disease Drugs Sales YoY (2021-2032) & (W Tons) Figure 24. South America, Middle East and Africa Chronic Kidney Disease Drugs Sales YoY (2021-2032) & (W Tons) Figure 25. Global Chronic Kidney Disease Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Chronic Kidney Disease Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Chronic Kidney Disease Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Chronic Kidney Disease Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Chronic Kidney Disease Drugs Revenue Market Share by Type (2021-2032) Figure 31. Global Chronic Kidney Disease Drugs Sales by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 32. Global Chronic Kidney Disease Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Chronic Kidney Disease Drugs Sales Market Share by Type (2021-2032) Figure 34. Global Chronic Kidney Disease Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Chronic Kidney Disease Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Chronic Kidney Disease Drugs Revenue Market Share by Application (2021-2032) Figure 37. Global Chronic Kidney Disease Drugs Sales by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 38. Global Chronic Kidney Disease Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Chronic Kidney Disease Drugs Sales Market Share by Application (2021-2032) Figure 40. North America Chronic Kidney Disease Drugs Revenue Share by Type (2021-2032) Figure 41. North America Chronic Kidney Disease Drugs Sales Share by Type (2021-2032) Figure 42. North America Chronic Kidney Disease Drugs Revenue Share by Application (2021-2032) Figure 43. North America Chronic Kidney Disease Drugs Sales Share by Application (2021-2032) Figure 44. North America Chronic Kidney Disease Drugs Revenue Share by Country (2021-2032) Figure 45. North America Chronic Kidney Disease Drugs Sales Share by Country (2021-2032) Figure 46. Europe Chronic Kidney Disease Drugs Revenue Share by Type (2021-2032) Figure 47. Europe Chronic Kidney Disease Drugs Sales Share by Type (2021-2032) Figure 48. Europe Chronic Kidney Disease Drugs Revenue Share by Application (2021-2032) Figure 49. Europe Chronic Kidney Disease Drugs Sales Share by Application (2021-2032) Figure 50. Europe Chronic Kidney Disease Drugs Revenue Share by Country (2021-2032) Figure 51. Europe Chronic Kidney Disease Drugs Sales Share by Country (2021-2032) Figure 52. China Chronic Kidney Disease Drugs Revenue Share by Type (2021-2032) Figure 53. China Chronic Kidney Disease Drugs Sales Share by Type (2021-2032) Figure 54. China Chronic Kidney Disease Drugs Revenue Share by Application (2021-2032) Figure 55. China Chronic Kidney Disease Drugs Sales Share by Application (2021-2032) Figure 56. Asia Chronic Kidney Disease Drugs Revenue Share by Type (2021-2032) Figure 57. Asia Chronic Kidney Disease Drugs Sales Share by Type (2021-2032) Figure 58. Asia Chronic Kidney Disease Drugs Revenue Share by Application (2021-2032) Figure 59. Asia Chronic Kidney Disease Drugs Sales Share by Application (2021-2032) Figure 60. Asia Chronic Kidney Disease Drugs Revenue Share by Country (2021-2032) Figure 61. Asia Chronic Kidney Disease Drugs Sales Share by Country (2021-2032) Figure 62. SAMEA Chronic Kidney Disease Drugs Revenue Share by Type (2021-2032) Figure 63. SAMEA Chronic Kidney Disease Drugs Sales Share by Type (2021-2032) Figure 64. SAMEA Chronic Kidney Disease Drugs Revenue Share by Application (2021-2032) Figure 65. SAMEA Chronic Kidney Disease Drugs Sales Share by Application (2021-2032) Figure 66. SAMEA Chronic Kidney Disease Drugs Revenue Share by Country (2021-2032) Figure 67. SAMEA Chronic Kidney Disease Drugs Sales Share by Country (2021-2032) Figure 68. Chronic Kidney Disease Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Chronic Kidney Disease Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Beta Blockers
  • Calcium Channel Blockers
  • Others
  • ACE Inhibitors
Applications
  • Hospitals
  • Specialty Clinics
Companies covered
  • AstraZeneca
  • F. Hoffmann-La Roche Ltd
  • Keryx Biopharmaceuticals, Inc
  • Kissei Pharmaceutical Co., Ltd
  • AbbVie
  • Amgen
  • GlaxoSmithKline
  • Pfizer
  • Sanofi
  • Teva Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Chronic Kidney Disease Drugs Market by Type
  3. 1.2.1 Global Chronic Kidney Disease Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Beta Blockers
  5. 1.2.3 Calcium Channel Blockers
  6. 1.2.4 Others
  7. 1.2.5 ACE Inhibitors
  8. 1.3 Chronic Kidney Disease Drugs Market by Application
  9. 1.3.1 Global Chronic Kidney Disease Drugs Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals
  11. 1.3.3 Specialty Clinics
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Chronic Kidney Disease Drugs Market Dynamics
  1. 2.1 Chronic Kidney Disease Drugs Industry Trends
  2. 2.2 Chronic Kidney Disease Drugs Industry Drivers
  3. 2.3 Chronic Kidney Disease Drugs Industry Opportunities and Challenges
  4. 2.4 Chronic Kidney Disease Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Chronic Kidney Disease Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Chronic Kidney Disease Drugs Revenue by Region
  3. 3.2.1 Global Chronic Kidney Disease Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Chronic Kidney Disease Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Chronic Kidney Disease Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Chronic Kidney Disease Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Chronic Kidney Disease Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Chronic Kidney Disease Drugs Sales by Region
  9. 3.4.1 Global Chronic Kidney Disease Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Chronic Kidney Disease Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Chronic Kidney Disease Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Chronic Kidney Disease Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Chronic Kidney Disease Drugs Revenue by Manufacturers
  2. 4.1.1 Global Chronic Kidney Disease Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Chronic Kidney Disease Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Chronic Kidney Disease Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Chronic Kidney Disease Drugs Sales by Manufacturers
  6. 4.2.1 Global Chronic Kidney Disease Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Chronic Kidney Disease Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Chronic Kidney Disease Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Chronic Kidney Disease Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Chronic Kidney Disease Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Chronic Kidney Disease Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Chronic Kidney Disease Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Chronic Kidney Disease Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Chronic Kidney Disease Drugs Market CR5 and HHI
  16. 4.8.2 2025 Chronic Kidney Disease Drugs Tier 1, Tier 2, and Tier 3
5 Chronic Kidney Disease Drugs Market by Type
  1. 5.1 Global Chronic Kidney Disease Drugs Revenue by Type
  2. 5.1.1 Global Chronic Kidney Disease Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Chronic Kidney Disease Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Chronic Kidney Disease Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Chronic Kidney Disease Drugs Sales by Type
  6. 5.2.1 Global Chronic Kidney Disease Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Chronic Kidney Disease Drugs Sales by Type (2021-2032) & (W Tons)
  8. 5.2.3 Global Chronic Kidney Disease Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Chronic Kidney Disease Drugs Price by Type
6 Chronic Kidney Disease Drugs Market by Application
  1. 6.1 Global Chronic Kidney Disease Drugs Revenue by Application
  2. 6.1.1 Global Chronic Kidney Disease Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Chronic Kidney Disease Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Chronic Kidney Disease Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Chronic Kidney Disease Drugs Sales by Application
  6. 6.2.1 Global Chronic Kidney Disease Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Chronic Kidney Disease Drugs Sales by Application (2021-2032) & (W Tons)
  8. 6.2.3 Global Chronic Kidney Disease Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Chronic Kidney Disease Drugs Price by Application
7 Company Profiles
  1. 7.1 AstraZeneca
  2. 7.1.1 AstraZeneca Company Information
  3. 7.1.2 AstraZeneca Business Overview
  4. 7.1.3 AstraZeneca Chronic Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AstraZeneca Chronic Kidney Disease Drugs Product Portfolio
  6. 7.1.5 AstraZeneca Recent Developments
  7. 7.2 F. Hoffmann-La Roche Ltd
  8. 7.2.1 F. Hoffmann-La Roche Ltd Company Information
  9. 7.2.2 F. Hoffmann-La Roche Ltd Business Overview
  10. 7.2.3 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Product Portfolio
  12. 7.2.5 F. Hoffmann-La Roche Ltd Recent Developments
  13. 7.3 Keryx Biopharmaceuticals, Inc
  14. 7.3.1 Keryx Biopharmaceuticals, Inc Company Information
  15. 7.3.2 Keryx Biopharmaceuticals, Inc Business Overview
  16. 7.3.3 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Product Portfolio
  18. 7.3.5 Keryx Biopharmaceuticals, Inc Recent Developments
  19. 7.4 Kissei Pharmaceutical Co., Ltd
  20. 7.4.1 Kissei Pharmaceutical Co., Ltd Company Information
  21. 7.4.2 Kissei Pharmaceutical Co., Ltd Business Overview
  22. 7.4.3 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Product Portfolio
  24. 7.4.5 Kissei Pharmaceutical Co., Ltd Recent Developments
  25. 7.5 AbbVie
  26. 7.5.1 AbbVie Company Information
  27. 7.5.2 AbbVie Business Overview
  28. 7.5.3 AbbVie Chronic Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 AbbVie Chronic Kidney Disease Drugs Product Portfolio
  30. 7.5.5 AbbVie Recent Developments
  31. 7.6 Amgen
  32. 7.6.1 Amgen Company Information
  33. 7.6.2 Amgen Business Overview
  34. 7.6.3 Amgen Chronic Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Amgen Chronic Kidney Disease Drugs Product Portfolio
  36. 7.6.5 Amgen Recent Developments
  37. 7.7 GlaxoSmithKline
  38. 7.7.1 GlaxoSmithKline Company Information
  39. 7.7.2 GlaxoSmithKline Business Overview
  40. 7.7.3 GlaxoSmithKline Chronic Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 GlaxoSmithKline Chronic Kidney Disease Drugs Product Portfolio
  42. 7.7.5 GlaxoSmithKline Recent Developments
  43. 7.8 Pfizer
  44. 7.8.1 Pfizer Company Information
  45. 7.8.2 Pfizer Business Overview
  46. 7.8.3 Pfizer Chronic Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Pfizer Chronic Kidney Disease Drugs Product Portfolio
  48. 7.8.5 Pfizer Recent Developments
  49. 7.9 Sanofi
  50. 7.9.1 Sanofi Company Information
  51. 7.9.2 Sanofi Business Overview
  52. 7.9.3 Sanofi Chronic Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Sanofi Chronic Kidney Disease Drugs Product Portfolio
  54. 7.9.5 Sanofi Recent Developments
  55. 7.10 Teva Pharmaceutical Industries
  56. 7.10.1 Teva Pharmaceutical Industries Company Information
  57. 7.10.2 Teva Pharmaceutical Industries Business Overview
  58. 7.10.3 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Product Portfolio
  60. 7.10.5 Teva Pharmaceutical Industries Recent Developments
8 North America
  1. 8.1 North America Chronic Kidney Disease Drugs Market Size by Type
  2. 8.1.1 North America Chronic Kidney Disease Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Chronic Kidney Disease Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Chronic Kidney Disease Drugs Price by Type (2021-2032)
  5. 8.2 North America Chronic Kidney Disease Drugs Market Size by Application
  6. 8.2.1 North America Chronic Kidney Disease Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Chronic Kidney Disease Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Chronic Kidney Disease Drugs Price by Application (2021-2032)
  9. 8.3 North America Chronic Kidney Disease Drugs Market Size by Country
  10. 8.3.1 North America Chronic Kidney Disease Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Chronic Kidney Disease Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Chronic Kidney Disease Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Chronic Kidney Disease Drugs Market Size by Type
  2. 9.1.1 Europe Chronic Kidney Disease Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Chronic Kidney Disease Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Chronic Kidney Disease Drugs Price by Type (2021-2032)
  5. 9.2 Europe Chronic Kidney Disease Drugs Market Size by Application
  6. 9.2.1 Europe Chronic Kidney Disease Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Chronic Kidney Disease Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Chronic Kidney Disease Drugs Price by Application (2021-2032)
  9. 9.3 Europe Chronic Kidney Disease Drugs Market Size by Country
  10. 9.3.1 Europe Chronic Kidney Disease Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Chronic Kidney Disease Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Chronic Kidney Disease Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Chronic Kidney Disease Drugs Market Size by Type
  2. 10.1.1 China Chronic Kidney Disease Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Chronic Kidney Disease Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Chronic Kidney Disease Drugs Price by Type (2021-2032)
  5. 10.2 China Chronic Kidney Disease Drugs Market Size by Application
  6. 10.2.1 China Chronic Kidney Disease Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Chronic Kidney Disease Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Chronic Kidney Disease Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Chronic Kidney Disease Drugs Market Size by Type
  2. 11.1.1 Asia Chronic Kidney Disease Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Chronic Kidney Disease Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Chronic Kidney Disease Drugs Price by Type (2021-2032)
  5. 11.2 Asia Chronic Kidney Disease Drugs Market Size by Application
  6. 11.2.1 Asia Chronic Kidney Disease Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Chronic Kidney Disease Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Chronic Kidney Disease Drugs Price by Application (2021-2032)
  9. 11.3 Asia Chronic Kidney Disease Drugs Market Size by Country
  10. 11.3.1 Asia Chronic Kidney Disease Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Chronic Kidney Disease Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Chronic Kidney Disease Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Chronic Kidney Disease Drugs Market Size by Type
  2. 12.1.1 SAMEA Chronic Kidney Disease Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Chronic Kidney Disease Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Chronic Kidney Disease Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Chronic Kidney Disease Drugs Market Size by Application
  6. 12.2.1 SAMEA Chronic Kidney Disease Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Chronic Kidney Disease Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Chronic Kidney Disease Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Chronic Kidney Disease Drugs Market Size by Country
  10. 12.3.1 SAMEA Chronic Kidney Disease Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Chronic Kidney Disease Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Chronic Kidney Disease Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Chronic Kidney Disease Drugs Value Chain Analysis
  2. 13.1.1 Chronic Kidney Disease Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Chronic Kidney Disease Drugs Production Mode & Process
  6. 13.2 Chronic Kidney Disease Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Chronic Kidney Disease Drugs Distributors
  9. 13.2.3 Chronic Kidney Disease Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst